GlaxoSmithKline Manufacturing SpA
FDA inspection history in Torrile, Italy, 2021
- 1
- Form 483
Every document, by year
- Form 483
2021: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2021One Form 483, at Torrile, Italy.
Cited most
Across all GlaxoSmithKline Manufacturing SpA observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.113Control of microbiological contamination1
The complete GlaxoSmithKline Manufacturing SpA file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Torrile, Italy
One Form 483 · 2021 · 1 observation
Latest: Form 483, Nov 12, 2021 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2021-11-12 | 483 Form 483 | Torrile, Italy | 1 | $99 |
Investigators on these documents
FEI number 3002807114 · most recent document Nov 12, 2021
About GlaxoSmithKline Manufacturing SpA
How many FDA Form 483s has GlaxoSmithKline Manufacturing SpA received?
FDA Intel has 1 Form 483 on file for GlaxoSmithKline Manufacturing SpA; the most recent is dated Nov 12, 2021.
When was GlaxoSmithKline Manufacturing SpA last inspected by FDA?
The most recent FDA inspection document on file for GlaxoSmithKline Manufacturing SpA is a Form 483 dated Nov 12, 2021, for the site in Torrile, Italy.
What did FDA cite at GlaxoSmithKline Manufacturing SpA?
The regulations cited most in the observations on file for GlaxoSmithKline Manufacturing SpA are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.113 (Control of microbiological contamination), 1 time.